Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method for predicting efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy, method for evaluating cancer grade, and method for enhancing efficacy of anti-PD-1 antibody or anti-PD-L1 antibody therapy

US Patent 11899019 · Granted Feb 13, 2024

Assignee

Inventors

View full patent text on Google Patents →